Search company, investor...

Slimedics

slimedics.com

Founded Year

2007

Stage

Other Investors | Alive

About Slimedics

Slimedics, founded in 2007, is developing an intra-gastric implant for the treatment of obesity, this device designed to be delivered and deployed inside the stomach and act as a counter force to the stomach grinding action. Slimedics device presence therefore will slow down the stomach emptying cycle from a normal 1-2 hours cycle to expect two to three times longer; during this period the patient feels full and therefore indirectly aims to reduce food consumption. The device will be introduced using a conventional, well known relatively simple and safe gastroscopic procedure requiring sedation and standard gastroscopic instrumentation. Slimedics first product is indicated for morbid obesity patients (Body mass index>40).

Headquarters Location

Israel

Missing: Slimedics's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Slimedics's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Slimedics Frequently Asked Questions (FAQ)

  • When was Slimedics founded?

    Slimedics was founded in 2007.

  • What is Slimedics's latest funding round?

    Slimedics's latest funding round is Other Investors.

  • Who are the investors of Slimedics?

    Investors of Slimedics include Xenia Venture Capital.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.